880399-00-8
Chemical Structure
GPVI antagonist 2
- CAS No.: 880399-00-8
- Formula:C24H27N3O4
- Molecular Weight:421.49
IUPAC Name: 4-(3-butoxyphenyl)-3-(2-hydroxyphenyl)-5-(3-hydroxypropyl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(1H)-one
InChIKey: MLGZFHLZGVILRC-UHFFFAOYSA-N
SMILES: O=C1N(CCCO)C(C2=CC=CC(OCCCC)=C2)C3=C1NN=C3C4=CC=CC=C4O
Biological Activity: GPVI antagonist 2 (Compound 1) is a potential antagonist of Glycoprotein VI (GPVI). IC50 values of GPVI antagonist 2 are, respectively, 0.35 μM for collagen, 0.80 μM for CRP, 195.2 μM for convulxin and 81.38 μM for thrombin. Glycoprotein VI (GPVI) is a platelet major collagen receptor and a target for potent and safe antithrombotic research. GPVI antagonist 2 is a promising antiplatelet agent[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GPVI antagonist 2 | 99.24% | GPVI antagonist 2 (Compound 1) is a potential antagonist of Glycoprotein VI (GPVI). IC50 values of GPVI antagonist 2 are, respectively, 0.35 μM for collagen, 0.80 μM for CRP, 195.2 μM for convulxin and 81.38 μM for thrombin. Glycoprotein VI (GPVI) is a platelet major collagen receptor and a target for potent and safe antithrombotic research. GPVI antagonist 2 is a promising antiplatelet agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
